TY - CHAP
T1 - Next-Generation Sequencing Analysis
AU - Velayutham, Dinesh
AU - Nisamudheen, Nismabi A.
AU - Mohammed, Fathima K.
AU - Al-Yafei, Randa S.
AU - Jithesh, Puthen Veettil
N1 - Publisher Copyright:
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025.
PY - 2025
Y1 - 2025
N2 - Next-generation sequencing (NGS) has revolutionized the process of scanning multiple fragmented DNA molecules simultaneously and sequencing them in parallel. The large amount of data generated needs to be analyzed carefully to extract important information in the genomes. Bioinformatics algorithms and tools have been developed in response to this challenge, enabling the large-scale analysis of NGS data. Such tools help in determining the quality of the sequence reads, alignment of the reads against reference genomes or de novo assembly, identifying the variants, annotating these variants with a vast array of datasets, and further analyses specific to the problem at hand. Bioinformatics has evolved along with the evolution of NGS technologies, for example, from short-read to long-read sequencing. NGS technologies, with the help of bioinformatics, have supported the development of genomics including disease-targeted sequencing, high-throughput metagenomics, and precision medicine implementation. Recent advances in NGS, including technologies such as single-cell sequencing and long-read sequencing, enhance the breadth and accuracy of genetic investigations to uncover the molecular causes of various diseases. Artificial intelligence (AI) and machine learning (ML) promise a future in which genomics not only informs healthcare but also predicts the risk of developing diseases, provides accurate diagnosis and treatment options, as well as predicts the outcome of the disease and response to treatment.
AB - Next-generation sequencing (NGS) has revolutionized the process of scanning multiple fragmented DNA molecules simultaneously and sequencing them in parallel. The large amount of data generated needs to be analyzed carefully to extract important information in the genomes. Bioinformatics algorithms and tools have been developed in response to this challenge, enabling the large-scale analysis of NGS data. Such tools help in determining the quality of the sequence reads, alignment of the reads against reference genomes or de novo assembly, identifying the variants, annotating these variants with a vast array of datasets, and further analyses specific to the problem at hand. Bioinformatics has evolved along with the evolution of NGS technologies, for example, from short-read to long-read sequencing. NGS technologies, with the help of bioinformatics, have supported the development of genomics including disease-targeted sequencing, high-throughput metagenomics, and precision medicine implementation. Recent advances in NGS, including technologies such as single-cell sequencing and long-read sequencing, enhance the breadth and accuracy of genetic investigations to uncover the molecular causes of various diseases. Artificial intelligence (AI) and machine learning (ML) promise a future in which genomics not only informs healthcare but also predicts the risk of developing diseases, provides accurate diagnosis and treatment options, as well as predicts the outcome of the disease and response to treatment.
KW - Analysis workflow
KW - Bioinformatics
KW - Exome sequencing
KW - Next-generation sequencing
KW - Targeted panel sequencing
KW - Whole genome sequencing
UR - https://www.scopus.com/pages/publications/105026630009
U2 - 10.1007/978-3-031-81728-1_36
DO - 10.1007/978-3-031-81728-1_36
M3 - Chapter
AN - SCOPUS:105026630009
T3 - Springer Handbooks
SP - 823
EP - 848
BT - Springer Handbooks
PB - Springer Science and Business Media Deutschland GmbH
ER -